Department of Veterans' Affairs CLIK

You are here

Injection of blood products

Document
Print version    Send email

Hepatitis D - Injection of blood products Factor

Last reviewed for CCPS 01 August 1995.

Investigative Documents

Claimant Report - Transfusion of Blood or Blood Products [CR9012]

Medical Report - Blood Transfusion and Injection of Blood Products - Hepatitis [MR9051]

Preliminary questions [10351]

10249

there is some evidence that a blood products injection may be a factor in the development of the condition under consideration.

7025 the veteran has had a blood product injection at some time.

10370 the veteran had a blood products injection more than 3 weeks before the clinical onset of hepatitis D.

10372

the blood products injection more than 3 weeks before the clinical onset of hepatitis D was screened for hepatitis D.

10373 — the veteran has established the causal connection between the blood product injection and VEA service for the clinical onset of hepatitis D.

10374 — the veteran has established the causal connection between the identified illness or injury which required the blood products injection and operational service for the clinical onset of hepatitis D.

or

10375 — the veteran has established the causal connection between the blood product injection and eligible service for the clinical onset of hepatitis D.

Clinical onset and operational service [10374]

11275

the unscreened blood products injection more than 3 weeks before the clinical onset of hepatitis D was given on operational service.

11276

the unscreened blood products injection more than 3 weeks before the clinical onset of hepatitis D was given on operational service, as a causal result of operational service.

11279

the receipt of the unscreened blood products injection more than 3 weeks before the clinical onset of hepatitis D, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

10371

the blood products injection more than 3 weeks before the clinical onset of hepatitis D was given for treatment of an illness or injury which is identifiable.

7029 — the identified illness or injury for which the blood product injection was given is causally related to operational service.

Clinical onset and eligible service [10375]

11277

the unscreened blood products injection more than 3 weeks before the clinical onset of hepatitis D was given on eligible service.

11278

the unscreened blood products injection more than 3 weeks before the clinical onset of hepatitis D was given on eligible service, as a causal result of eligible service duties.

11280

the receipt of the unscreened blood products injection more than 3 weeks before the clinical onset of hepatitis D, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

10371

the blood products injection more than 3 weeks before the clinical onset of hepatitis D was given for treatment of an illness or injury which is identifiable.

10256 — the identified illness or injury for which the blood product injection was given is causally related to eligible service.

About CLIK

The Consolidated Library of Information and Knowledge (CLIK) contains all the legislative, policy and reference material used by DVA staff in providing service to the clients of the Department of Veterans' Affairs.

How to use CLIK

Follow DVA

Sitemap

Compensation & Support

Military Compensation

Health

Reports, Studies & Research Papers Library

SOP Information

Rehabilitation